ArticleCancers2026
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer.
Marc A Pina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancers2026
Marc A Pina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.